PTEN and diabetic kidney disease: The AMP-activated protein kinase (AMPK), Phosphatase and tensin homolog (PTEN) and Akt2 signaling regulate mTOR activation and represent potential targets of novel drugs for reducing glomerular damage in DKD patients.